BD Rx gains FDA nod for generic injectable vomiting drug

04/23/2013 | Drug Store News

BD Rx received federal approval for its metoclopramide injectable drug to address vomiting. The drug is the second product to be approved among the BD Simplist line of pre-filled generic injectables, designed to reduce the number of steps needed before administration.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA